| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $155.6M | +31.3% |
| Cost of Revenue | $95.2M | +36.0% |
| R&D Expense | $2.7M | +28.6% |
| SG&A Expense | $58.3M | +18.8% |
| Operating Income | -$2.3M | +56.0% |
| Pre-tax Income | -$601K | +82.9% |
| Income Tax | $351K | +33.5% |
| Net Income | -$1.1M | +76.7% |
| EPS (Basic) | -$0.45 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.2M | -26.8% |
| Accounts Receivable | $27.8M | +14.2% |
| Inventory | $37.0M | +9.2% |
| Current Assets | $87.7M | -0.9% |
| Total Assets | $138.6M | -2.6% |
| Current Liabilities | $17.7M | -10.7% |
| Long-term Debt | $6.4M | +1.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.4M | -112.3% |
| Capital Expenditures | $1.0M | +109.1% |
| Investing Cash Flow | -$698K | -57.2% |
| Financing Cash Flow | -$2.7M | +35.7% |
| Free Cash Flow | -$2.5M | -122.2% |
| +77.3% |
| EPS (Diluted) | -$0.45 | +77.3% |
| Total Liabilities |
| $29.3M |
| -7.3% |
| Stockholders' Equity | $91.0M | -1.7% |